Sign in

CIK 0001504776

  • Large accelerated filer

Warby Parker Inc.

Sign in to watch
Ticker
WRBY
Exchange
NYSE
Industry
Ophthalmic Goods
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
800423634
Phone
+1 646-847-7215
Business address
233 SPRING STREET, 6TH FLOOR EAST, NEW YORK, NY, 10013
Former names
JAND, Inc.
  1. 4 Grant or award Director acquired 9,004 shares (grant or award)
  2. 4 Grant or award Director acquired 12,005 shares (grant or award)
  3. 4 Grant or award Director acquired 9,004 shares (grant or award)
  4. 4 Grant or award Director acquired 9,004 shares (grant or award)
  5. 4 Shares withheld for taxes Co-Chief Executive Officer gave up 11,505 shares (to pay taxes)
  6. 4 Shares withheld for taxes Co-Chief Executive Officer gave up 11,505 shares (to pay taxes)
  7. 4 Planned sale Co-Chief Executive Officer sold 63,040 shares at $30.03 ($1,893,091)
  8. 4 Open-market sale Director sold 25,000 shares at an average $28.61 ($715,167)
  9. 4 Planned sale Co-Chief Executive Officer sold 100,000 shares at an average $24.67 ($2,467,130)
  10. 4 Open-market sale Director sold 25,000 shares at $25.43 ($635,750)
  11. 4 Shares withheld for taxes Co-Chief Executive Officer gave up 7,453 shares (to pay taxes)
  12. 4 Shares withheld for taxes Co-Chief Executive Officer gave up 7,453 shares (to pay taxes)
  13. 4 Open-market sale Director sold 15,793 shares at $27.53 ($434,781)
  14. 4 Shares withheld for taxes Co-Chief Executive Officer gave up 8,943 shares (to pay taxes)
  15. 4 Shares withheld for taxes Co-Chief Executive Officer gave up 8,943 shares (to pay taxes)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Planned sale Co-Chief Executive Officer sold 660 shares at $29.99 ($19,793)
  19. 4 Planned sale Co-Chief Executive Officer sold 80,094 shares at $29.46 ($2,359,569)
  20. 4 Planned sale Co-Chief Executive Officer sold 94,906 shares at an average $27.51 ($2,610,816)

Page 2 of 13 · 260 filings